Burlingame
Lyra Health is a provider of comprehensive mental health care benefits for employers.
Estimated valuation today
$369M
-93.53% since last round
Calculated based on estimated multiplier and revenue.
Estimated multiplier for Lyra Health
2.46x revenue
Calculated based on public comps and hype multiple.
Revenue
Update this based on your knowledge or projections. Calculations use last 12 months revenue.
Hype Multiple
Currently selected comps have a median growth rate of 11.40%
This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.
multiple
In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.
The last round was 7 months ago.
Date
January 2022
Valuation
$5.7B
Amount raised
$235M
We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.
Multiple at last round
1.94x revenue
Today's multiple
1.64x revenue
Change
-15.41%
Companies
Industry – Healthcare
Last updated 5 mins ago.
| Remove | Name | Ticker | Price multiple |
|---|---|---|---|
| Lyra Health | 1.64x | ||
| 1Life Healthcare Inc | ONEM | 4.38x | |
| HCA Holdings Inc | HCA | 1.04x | |
| Tenet Healthcare Corporation | THC | 0.37x | |
| Quest Diagnostics Incorporated | DGX | 1.51x | |
| Humana Inc | HUM | 0.67x |
| Date | Round | Amount raised | Price per share (Preferred) | Valuation |
|---|---|---|---|---|
| Jan 2022 | Series G | $235MM | $18.23 | $5.7B |
| Jun 2021 | Series F | $210.35MM | $15.70 | $4.65B |
| Jan 2021 | Series E | $186.69MM | $9.16 | $2.25B |
| Aug 2020 | Series D | $112.5MM | $4.74 | $1.2B |
| Mar 2020 | Series C | $82MM | $2.83 | $612.56MM |
| May 2018 | Series B | $61.03MM | $1.36 | $246MM |
| Oct 2015 | Series A | $35MM | $1.03 | $111.71MM |
| Jun 2015 | Series Seed II | $3.23MM | $0.17 | $11.72MM |
| Jun 2015 | Series Seed | $999K | $0.03 | $1.42MM |
With a revenue of $150M and a Hype Multiple of 1.5x,
Lyra Health is estimated to be worth $369M.